These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children. Basu B; Babu BG; Mahapatra TK Clin Exp Nephrol; 2017 Feb; 21(1):143-151. PubMed ID: 27108294 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome. Abeyagunawardena AS; Karunadasa U; Jayaweera H; Thalgahagoda S; Tennakoon S; Abeyagunawardena S Pediatr Nephrol; 2017 Aug; 32(8):1363-1367. PubMed ID: 28299461 [TBL] [Abstract][Full Text] [Related]
18. Short- and long-term efficacy of levamisole in children with steroid-sensitive nephrotic syndrome. Elmas AT; Tabel Y; Elmas ON Int Urol Nephrol; 2013 Aug; 45(4):1047-55. PubMed ID: 22826143 [TBL] [Abstract][Full Text] [Related]
19. [Verification of indications for kidney biopsy in children with steroid-dependent nephrotic syndrome]. Idczak-Nowicka E; Ksiazek J; Kryński J; Wyszyńska T Pediatr Pol; 1996 Aug; 71(8):679-83. PubMed ID: 8927471 [TBL] [Abstract][Full Text] [Related]
20. Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children. Dayal U; Dayal AK; Shastry JC; Raghupathy P Nephron; 1994; 66(4):408-12. PubMed ID: 8015643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]